REGENERON PHARMACEUTICALS, INC.: accounts_receivable

Value{"amount": 5222200000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2024-03-31)
Statuscurrent
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001804220-24-000017
Retrieved: 2026-08-19T08:39:12.123968+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2024-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ca8c728a-3f16-44c1-8bfe-e9d69c69bd7c

History